An early warning test for Alzheimer’s disease could enable doctors to deliver treatment 10 years before a diagnosis is usually made, helping to delay the onset of symptoms.
Researchers at the Mayo Clinic in the US have developed a tool to estimate the risk of a person developing memory and thinking problems associated with Alzheimer's disease, years before symptoms first appear.
In its early stages, the condition can be notoriously difficult to diagnose. Common indicators such as memory loss and confusion can be related to the effects of ageing, while patients often conceal memory loss – further delaying diagnosis.
Research, published in The Lancet Neurology journal, built on decad
Continue Reading on The National UAE
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.